HQL vs VXUS

HQL vs VXUS

Which is better, HQL or VXUS?

We do not have enough on HQL and VXUS to separate them.

MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.

Side-by-Side Comparison

MetricHQLVXUS
Expense Ratio-0.05%
AUM-$158.1B
Dividend Yield-2.59%
Holdings-8,747
YTD Price Return-+15.51%
1Y Price Return-+23.98%
3Y Price Return (annualized)-+16.84%
5Y Price Return (annualized)-+5.72%
Volatility (annualized)-15.1%
Max Drawdown--39.9%
Fund Familyabrdn Life Sciences InvestorsVanguard (US)
Category-Equity
Style-Large Cap Blend
Inception-Jan 26, 2011

Not shown on this pair: $10,000 over the window, Top 10 Weight.

Returns are price returns and exclude distributions, because our data feed carries no adjusted close for HQL. We have no price series for HQL, so there is nothing to compare it against.

HQL vs VXUS Performance

abrdn Life Sciences Investors (HQL) is an ETF from abrdn Life Sciences Investors and Vanguard Total International Stock ETF (VXUS) is an ETF from Vanguard (US).

You are not choosing between two funds in isolation.

Whichever of HQL and VXUS you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.

HQLVXUS

Free for up to 10 holdings. No account needed.

Frequently Asked Questions

Is VXUS better than HQL?

We hold very little data on HQL and VXUS, so there is not enough here to separate them. Which one suits a particular account depends on what it is for. This is information, not a recommendation.